104 -New FDA Guidance, HF vs. Design Validation, Critical Tasks & Pre-IND HF Studies with Sara McNew

Podcast episode cover

September 27, 2023

104 -New FDA Guidance, HF vs. Design Validation, Critical Tasks & Pre-IND HF Studies with Sara McNew

[episode_spotify]

Share

Show Notes

On this episode, I was joined by Sara Waxberg MacNew, Chief Scientific Officer at Design Sciences. On this episode Sara and I discuss:

Sara Waxberg McNew is the Chief Scientific Officer at Design Science, a human factors firm that specializes in healthcare. Sara has held roles previously in user centered design leadership at Eli Lilly, Philips Healthcare, and Baxter Healthcare. She is an active member of AAMI where she has contributed to the development and revision of human factors technical information reports and international standards. Learn more about Design Science's impact on Healthcare Technology by following @designscience on all social media platforms.

Join Our news Letter

By signing up, you agree to receive email from this podcast.

Recent Episodes

October 5, 2026

257 – 21 CFR Part 4 Explained: CGMP Requirements for Combination Products

September 28, 2026

256 – The New FDA Inspection Playbook: Where to Start with QMSR

September 21, 2026

255 – Audit Interview Techniques: How Good Auditors Get Better Evidence

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.